英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

balsa    音标拼音: [b'ɔlsə]
n. 一种轻质木材,筏

一种轻质木材,筏

balsa
n 1: strong lightweight wood of the balsa tree used especially
for floats [synonym: {balsa}, {balsa wood}]
2: forest tree of lowland Central America having a strong very
light wood; used for making floats and rafts and in crafts
[synonym: {balsa}, {Ochroma lagopus}]



安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Libtayo more favorable than Keytruda for first-line . . .
    The FDA approved Libtayo in 2022 as a first-line treatment for advanced NSCLC, in combination with chemotherapy However, it has been unclear whether this new combination treatment could outperform Keytruda plus chemotherapy from a cost-effectiveness standpoint
  • What is Advanced CSCC? | LIBTAYO® (cemiplimab-rwlc)
    It is important to remember that these are only some examples, and CSCC can look different in every patient For more information on what CSCC may look like, please visit the Skin Cancer Foundation site to view other examples and warning signs of CSCC The inclusion of the organization listed above does not imply endorsement of LIBTAYO or
  • Libtayo (cemiplimab) vs Krazati (adagrasib) - Everyone. org
    Libtayo (cemiplimab) vs Krazati (adagrasib) Libtayo (cemiplimab) and Krazati (adagrasib) are both used in the treatment of certain types of cancer, but they have different mechanisms of action and indications
  • LIBTAYO® Full Prescribing Information | Regeneron
    1 3 Non-Small Cell Lung Cancer LIBTAYO in combination with platinum-based chemotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 aberrations and is:
  • Libtayo: Side effects, how it works, cost, alternatives, and more
    Libtayo (cemiplimab-rwlc) is a brand-name injection that’s used for certain types of lung and skin cancer Learn about side effects and more
  • What treatment options are available for a patient with . . .
    Treatment Algorithm for Recurrent Metastatic Cervical Cancer After Platinum Failure Second-Line Treatment Selection Cemiplimab 350 mg IV every 3 weeks is an appropriate option regardless of PD-L1 status, based on NCCN recommendations and phase III evidence 1, 4 Alternative second-line options per NCCN include:
  • label - accessdata. fda. gov
    1 3 Non-Small Cell Lung Cancer LIBTAYO in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 aberrations and is:
  • Patient Resources for LIBTAYO® (cemiplimab-rwlc) | Advanced NSCLC
    LIBTAYO patient brochures These brochures provide important information about advanced NSCLC and what you can expect from treatment with LIBTAYO
  • Treating Squamous Cell Carcinoma | Squamous Cell Cancer . . .
    Treating advanced squamous cell cancers Different types of treatments might be used for SCCs that have spread beyond the skin Lymph node dissection: Removing regional (nearby) lymph nodes might be recommended for some SCCs that are very large or have grown deeply into the skin, as well as if the lymph nodes feel enlarged and or hard
  • Libtayo: Uses, Side Effects, Warnings - Drugs. com
    Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications





中文字典-英文字典  2005-2009